Form 4: Regeneron Director Christine Poon Reports Stock and Option Transactions
SEC Form 4
Director Christine Poon reports acquisition of common stock and stock options in Regeneron Pharmaceuticals.
Summary
- On December 20, 2024, Christine Poon acquired 14 shares of common stock at $0.00.
- On January 2, 2025, Christine Poon acquired 166 shares of common stock at $0.00.
- Following these transactions, Poon directly owns 2,352 shares of Regeneron common stock.
- On January 2, 2025, Poon acquired 1,958 non-qualified stock options with an exercise price of $719.37, exercisable starting January 2, 2025, and expiring on January 2, 2035.
- Poon directly owns 1,958 derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock and option transactions. The transactions themselves don't inherently indicate positive or negative sentiment, but rather reflect compensation and investment decisions.
Positives
- The acquisition of stock and options by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies like Regeneron. These transactions are closely monitored by investors for insights into management's perspective on the company's value and future prospects.
Comparison to Industry Standards
- Insider trading activity is a common metric used to assess company health.
- Comparing Christine Poon's transactions to those of other directors in similar pharmaceutical companies (e.g., Amgen, Gilead) could provide context on whether this activity is typical or noteworthy.
- The size and frequency of these transactions can be benchmarked against industry averages for executive compensation and stock ownership.
Stakeholder Impact
- Shareholders may view these transactions as an indicator of management's confidence in the company.
- Employees may see this as part of the overall compensation structure.
Key Dates
| Date | Description |
|---|---|
| 12/20/2024 | Christine Poon acquired 14 shares of common stock. |
| 01/02/2025 | Christine Poon acquired 166 shares of common stock and 1,958 non-qualified stock options. |
| 01/06/2025 | Date of signature for the Form 4 filing. |
| 01/02/2035 | Expiration date of the non-qualified stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.